Some studies have identified significant associations of NTRK2 gene polymorphisms with responses to lithium drug treatment in patients with bipolar disorder [59,60], Alzheimer’s disease [61] or cognitive performance in the elderly [62]. The gene discussed is NTRK2; the disease is Alzheimer disease.